The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Method For Inactivation/Removal Of Coagulation Factors By Precipitation - EP2670429

The patent EP2670429 was granted to Octapharma on Apr 4, 2018. The application was originally filed on Feb 3, 2012 under application number EP12702825A. The patent is currently recorded with a legal status of "Revoked".

EP2670429

OCTAPHARMA
Application Number
EP12702825A
Filing Date
Feb 3, 2012
Status
Revoked
Jul 23, 2021
Publication Date
Apr 4, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 4, 2019CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
BIOTESTDec 21, 2018MEWBURN ELLISADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2005082937
EXAMINATIONWO2007085626
INTERNATIONAL-SEARCH-REPORTEP0987274
INTERNATIONAL-SEARCH-REPORTEP1816201
INTERNATIONAL-SEARCH-REPORTGB906860
OPPOSITIONEP0893450
OPPOSITIONEP0987274
OPPOSITIONEP1816201
OPPOSITIONGB906860
OPPOSITIONWO2005082937
OPPOSITIONWO2007085626
OPPOSITIONWO9943362
OTHERWO2005082937
OTHERWO2007085626

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents